Halozyme Therapeutics, Inc. (BMV:HALO)
Mexico flag Mexico · Delayed Price · Currency is MXN
1,275.01
+75.01 (6.25%)
At close: Nov 4, 2025

Halozyme Therapeutics Ratios and Metrics

Millions MXN. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
135,500126,74882,540150,073116,003114,707
Upgrade
Market Cap Growth
17.68%53.56%-45.00%29.37%1.13%134.71%
Upgrade
Enterprise Value
150,726144,848100,236174,383117,299115,751
Upgrade
Last Close Price
1275.01680.00680.00679.74775.07-
Upgrade
PE Ratio
12.4113.7017.3438.0614.0544.66
Upgrade
PS Ratio
5.945.995.8911.6612.7621.54
Upgrade
PB Ratio
14.6616.7258.2645.3128.7338.17
Upgrade
P/TBV Ratio
----28.7338.17
Upgrade
P/FCF Ratio
12.2612.9913.0832.7018.99108.87
Upgrade
P/OCF Ratio
12.0912.7012.5732.0418.90103.95
Upgrade
EV/Sales Ratio
6.676.857.1513.5412.9121.74
Upgrade
EV/EBITDA Ratio
10.0811.0914.2226.6020.6339.89
Upgrade
EV/EBIT Ratio
11.2312.6117.4330.8920.7440.33
Upgrade
EV/FCF Ratio
13.6414.8415.8837.9919.20109.86
Upgrade
Debt / Equity Ratio
3.054.2218.279.074.472.66
Upgrade
Debt / EBITDA Ratio
1.872.423.594.543.152.71
Upgrade
Debt / FCF Ratio
2.563.284.106.552.957.59
Upgrade
Asset Turnover
0.570.540.460.450.530.47
Upgrade
Inventory Turnover
1.651.772.362.672.041.72
Upgrade
Quick Ratio
1.256.505.074.547.101.11
Upgrade
Current Ratio
1.597.806.645.657.911.32
Upgrade
Return on Equity (ROE)
124.50%198.42%222.07%110.23%231.44%106.33%
Upgrade
Return on Assets (ROA)
21.24%18.16%11.89%12.28%20.47%15.74%
Upgrade
Return on Capital (ROIC)
22.87%19.61%12.78%12.98%21.16%17.11%
Upgrade
Return on Capital Employed (ROCE)
53.30%28.70%21.00%16.90%27.90%91.00%
Upgrade
Earnings Yield
8.06%7.30%5.77%2.63%7.12%2.24%
Upgrade
FCF Yield
8.15%7.70%7.65%3.06%5.27%0.92%
Upgrade
Buyback Yield / Dilution
3.31%3.56%4.56%4.21%-3.77%1.99%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.